Clinical Trials on Percutaneous Coronary in Canada

Total 504 results

Population Health Research Institute

Recruiting

Higher vs. Lower Dose Heparin for PCI (HD-PCI)

Cardiovascular Diseases | Percutaneous Coronary Intervention

Canada
Ottawa Heart Institute Research Corporation

Terminated

A Novel Strategy For Personalized Long-Term Dual Antiplatelet Therapy (RAPID EXTEND PILOT STUDY)

Percutaneous Coronary Intervention | Ticagrelor | Antiplatelet Therapy | Stable Coronary Syndrome

Canada
Portola Pharmaceuticals

Completed

A Phase 2 Safety and Efficacy Study of PRT060128, a Novel Intravenous and Oral P2Y12 Inhibitor, in Non-Urgent PCI (INNOVATE-PCI)

Percutaneous Coronary Intervention

United States, Austria, Canada, Germany, Poland
Sanofi

Completed

The SEPIA-PCI Trial: Otamixaban in Comparison to Heparin in Subjects Undergoing Non-Urgent Percutaneous Coronary Intervention (SEPIA-PCI)

Angioplasty, Transluminal, Percutaneous Coronary

United States, Spain, Belgium, Canada, South Africa, Netherlands, Germany, France, Czech Republic, Slovakia
Hopital du Sacre-Coeur de Montreal

Completed

H2 Haplotype and CYP3As Polymorphisms and the Antiplatelet Response to Clopidogrel

Coronary Artery Disease | Elective Percutaneous Coronary Intervention

Canada
Ottawa Heart Institute Research Corporation
Spartan Bioscience Inc.

Completed

ReAssessment of Anti-Platelet Therapy Using an InDividualized Strategy Based on GENetic Evaluation (RAPID GENE)

Acute Coronary Syndrome | Percutaneous Coronary Intervention | Stable Coronary Artery Disease

Canada
Ottawa Heart Institute Research Corporation
Canadian Institutes of Health Research (CIHR)

Completed

A Pharmacodynamic Study of a Personalized Strategy for P2Y12 Inhibition Versus Ticagrelor in Reducing Ischemic and Bleeding Risk (RAPID MANAGE)

Acute Coronary Syndrome | Percutaneous Coronary Intervention

Canada
University Health Network, Toronto
Stony Brook University; York University

Completed

Cardiac Rehabilitation Peer Mentorship

Coronary Artery Disease | Acute Coronary Syndrome | Percutaneous Coronary Intervention | Chronic Stable Heart Failure | Coronary Artery Bypass Graft Surgery, With or Without Valve Surgery

Canada
University of Alberta

Withdrawn

Electrically Guided Needle Insertion: ICU Study

Percutaneous Tracheostomy

Canada
Population Health Research Institute
Heart and Stroke Foundation of Canada

Recruiting

Adjunctive, Low-dose tPA in Primary PCI for STEMI (STRIVE)

Myocardial Infarction | Percutaneous Coronary Intervention

Canada
Population Health Research Institute
Sanofi

Completed

A Trial of Trans-radial Versus Trans-femoral Percutaneous Coronary Intervention (PCI) Access Site Approach in Patients With Unstable Angina or Myocardial Infarction Managed With an Invasive Strategy (RIVAL)

Acute Coronary Syndrome | Percutaneous Coronary Intervention

Canada
University of British Columbia
Vancouver Coastal Health; VGH and UBC Hospital Foundation

Completed

The StoneBreakerTM Trial

Percutaneous Nephrolithotripsy

Canada
Fundación EPIC

Recruiting

VerifyNow to Optimise Platelet Inhibition in Coronary Acute Syndrome (VERONICA)

Coronary Artery Disease | Acute Coronary Syndrome | Percutaneous Coronary Intervention | Acute Myocardial Infarction

Spain
Queen Elizabeth II Health Sciences Centre
Nova Scotia Health Research Foundation

Completed

Prevention of Instent Renarrowing With Aggressive Glucose Lowering With Pioglitazone in Diabetic Patients (PPAR-G)

Coronary Artery Disease | Type 2 Diabetes Mellitus | Angina Pectoris | Percutaneous Coronary Intervention

Canada
Janssen Scientific Affairs, LLC
Bayer

Completed

A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention (PIONEER AF-PCI)

Atrial Fibrillation | Percutaneous Coronary Intervention

United States, France, Poland, Ukraine, United Kingdom, Belgium, Germany, Taiwan, Argentina, Mexico, Bulgaria, Malaysia, Romania, Russian Federation, South Africa, Turkey, Korea, Republic of, Australia, Canada, Netherlands, Denmark and more
Boehringer Ingelheim

Completed

Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI)

Atrial Fibrillation | Percutaneous Coronary Intervention

Canada, United States, Spain, Korea, Republic of, Australia, Germany, Taiwan, Hong Kong, Thailand, United Kingdom, Turkey, Netherlands, Ireland, Hungary, Croatia, Colombia, Israel, Singapore, Italy, New Zealand, Greece, Mexico, Norway, Swed... and more
Population Health Research Institute

Completed

A Trial of Routine Aspiration Thrombectomy With Percutaneous Coronary Intervention (PCI) Versus PCI Alone in Patients With ST-Segment Elevation Myocardial Infarction (STEMI) Undergoing Primary PCI (TOTAL)

ST Elevation Myocardial Infarction | Acute Coronary Syndrome | Percutaneous Coronary Intervention

Canada, United States, Korea, Republic of, United Kingdom, Spain, New Zealand, France, Greece, Austria, Netherlands, Germany, Finland, Serbia, Czech Republic, Australia, Hungary, Brazil, Belgium, China, Macedonia, The Former Yugoslav...
Cogentus Pharmaceuticals

Terminated

Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1) (COGENT-1)

Myocardial Infarction | Coronary Artery Disease | Acute Coronary Syndrome | Percutaneous Coronary Intervention

United States, France, Canada, Australia, Poland, Germany, Italy, Mexico, Romania, Slovakia, Hungary, Czech Republic, Chile, Bulgaria, Puerto Rico, Ukraine
Faraday Pharmaceuticals, Inc.

Recruiting

Evaluation in STEMI Patients Using FDY-5301 (IOCYTE AMI-3)

Acute Myocardial Infarction | STEMI | Percutaneous Coronary Revascularization

United States, Israel, Poland, Portugal, Hungary, Canada
Ottawa Heart Institute Research Corporation

Terminated

Prophylactic Intra-coronary Adenosine to Prevent Post Coronary Artery Stenting Myonecrosis

Coronary Artery Disease | Coronary Artery Stenosis

Canada
Bracco Diagnostics, Inc

Terminated

Kidney Damage In Patients With Severe Fall In eGFR

Coronary Artery Stenosis

Canada
University of Alberta

Completed

Heparin Dose for Radial Angiography

Coronary Angiograph

Canada
Centre de Recherche de l'Institut Universitaire...
Canadian Institutes of Health Research (CIHR); Boston Scientific Corporation

Terminated

Sealing Moderate Coronary Saphenous VEin Graft Lesions With Paclitaxel-Eluting Stents (VELETI II)

Coronary Artery Bypass Grafting

Canada
Laval University
Boston Scientific Corporation

Completed

Treatment of Moderate Vein Graft Lesions With Paclitaxel Drug Eluting Stents: The VELETI Trial (VELETI)

Coronary Artery Bypass Grafting

Canada
Unity Health Toronto
University of Toronto

Completed

Arterial Closure vs Direct Compression for Hemostasis After PCI - The ACDC Trial

Coronary Artery Disease | Coronary Angioplasty

Canada
Laval University
Quebec Heart Institute

Recruiting

Physiology and Residual Ischemia After Percutaneous Coronary Intervention (EASY-PRIPCI)

Coronary Artery Disease | Chest Pain | Angina Pectoris | Ischemic Heart Disease | Coronary Restenosis

Canada
AusculSciences Canada Inc.
Ottawa Heart Institute Research Corporation

Unknown

A Novel Non-Invasive Acoustic Diagnostic for the Diagnosis of Coronary Artery Disease The CAD-det Validation Study

Cardiovascular Diseases | Coronary Artery Disease | Atherosclerosis | Coronary Occlusion

Canada
Sunnybrook Health Sciences Centre

Unknown

A Lead Rectangle to Lower the Operator's Radiation Exposure

Coronary Artery Disease | Atherosclerosis | Coronary Occlusion

Canada
Ottawa Heart Institute Research Corporation
Ontario Ministry of Health and Long Term Care; Heart and Stroke Foundation...

Completed

Investigating the Effects of Cardiac Rehabilitation eXercise Modalities on Physical and Mental Health Outcomes (CRX-Modalities)

Coronary Artery Disease (CAD)

Canada
Hamilton Health Sciences Corporation
Bristol-Myers Squibb

Completed

Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting: The PAPA CABG Study (PAPA CABG)

Coronary Artery Disease | Coronary Artery Bypass Grafting

Canada
University of Calgary
Canadian Institutes of Health Research (CIHR)

Completed

Double-Blind Comparison of Combined General-Spinal Anesthesia to General Anesthesia for Coronary Artery Surgery

Coronary Artery Disease | Coronary Artery Bypass Surgery

Canada
Matthias Friedrich

Recruiting

Breathing-Maneuver-Induced Myocardial Oxygenation Reserve Validated by FFR (B-MORE) (B-MORE)

Coronary Artery Stenosis

Canada
Montreal Heart Institute

Completed

High Frequency Ventilation During Off Pump Coronary Artery Bypass Graft (CABG) (VHF)

Coronary Artery Bypass Graft

Canada
Hamilton Health Sciences Corporation

Completed

Comparing Point of Care Clotting Tests in the OR Versus Standard Laboratory Clotting Tests

Coronary Artery Bypass Grafting

Canada
London Health Sciences Centre

Terminated

Starch or Saline After Cardiac Surgery (SSACS)

Coronary Artery Bypass Surgery

Canada
Ottawa Heart Institute Research Corporation
GE Healthcare

Recruiting

Cadmium-zinc-telluride (CZT) Imaging of Myocardial Blood Flow (MBF) (SPECT MBF) (SPECT MBF)

Coronary Heart Disease

Canada
Ottawa Heart Institute Research Corporation

Completed

Exercise Training in Women With Heart Disease (EXCEED)

Cardiovascular Diseases | Coronary Heart Disease

Canada
University of Calgary

Completed

The IMPART Study: The Impact of Patient Education in Cardiac Rehabilitation

Coronary Artery Disease | Acute Coronary Syndrome

Canada
Ottawa Heart Institute Research Corporation

Completed

Utility of a Smart Phone Application in Assessing Radial Artery Patency - the CAPITAL iRADIAL Study

Coronary Heart Disease

Canada
University of Toronto
Canadian Institutes of Health Research (CIHR); Quaker Oats Centre of Excellence...

Active, not recruiting

Meta-analysis of Oat Fiber and Cardiovascular Risk Reduction

Cardiovascular Diseases | Coronary Heart Disease

Canada
Montreal Heart Institute
Fonds de la Recherche en Santé du Québec

Completed

Individualized Exercise Training Based on the Heart Rate Variability in Coronary Heart Disease Patient (HRV-Predict)

Coronary Artery Disease

Canada
Ottawa Heart Institute Research Corporation
Heart and Stroke Foundation of Canada

Completed

Family Heart Health Program: Randomized, Controlled Trial (FHHP-RCT)

Coronary Heart Disease

Canada
Ottawa Heart Institute Research Corporation
Heart and Stroke Foundation of Ontario

Completed

Varenicline Versus Transdermal Nicotine Patch for Smoking Cessation in Patients With Coronary Heart Disease

Coronary Heart Disease

Canada
University Health Network, Toronto

Completed

Relaxation Music to Lower Heart Rate Prior to Cardiac CT

Coronary Artery Disease and Cardiac Anatomy | Patients Undergoing Coronary CT Angiogram | Patients Undergoing CT Pulmonary Vein Angiogram | Patients Undergoing CT Calcium Score

Canada
Montreal Heart Institute

Completed

Periodization of Exercise Training in Patients With Coronary Heart Disease. (PERIOD)

Coronary Heart Disease | Healthy Control

Canada
Unity Health Toronto

Unknown

Arterial Closure Device Comparison Trial II - ACDC Trial II

Arterial Hemostasis After Coronary Intervention

Canada
Ottawa Heart Institute Research Corporation

Recruiting

Peer Support for Women With Heart Disease: Women@Heart

Coronary Heart Disease | Women's Health

Canada
Hamilton Health Sciences Corporation
GlaxoSmithKline

Unknown

Fondaparinux to Prevent Thrombotic Complications and Graft Failure in Patients Undergoing Coronary Artery Bypass Graft Surgery: The Fonda CABG Study (Fonda CABG)

Coronary Bypass Graft Failure/Occlusion

Canada
University of Manitoba
WhiteWave Foods, Inc.

Completed

Efficacy of Sterol Enhanced Soy Beverage on Cholesterol Metabolism, Inflammation and Oxidative Status in Humans

Coronary Heart Disease

Canada
Trillium Health Centre
Toshiba America Medical Systems, Inc.

Unknown

Graft Patency in Beating Heart Vs. Conventional CABG Using Cardiac CT

Coronary Artery Disease Amenable to Bypass Graft Surgery

Canada

Clinical Trials on Percutaneous Coronary in Canada

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Equatorial Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations